Physician profile
Robin Theo Mitchell
NPI 1659785582
$1,528.68
in general payments reported to CMS, 2019-2025
12 companies · $51.59 in 2025
The $51.59 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $558 · 2023: $309 · 2024: $487 · 2025: $51.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $499.55 | 2022-2024 | Freestyle Libre 3, 2nd Gen Centrimag Primary Console |
| Lilly USA, LLC | $221.75 | 2022-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $156.03 | 2024 | Airsupra |
| Insmed, INC. | $125.00 | 2022 | |
| Idorsia Pharmaceuticals US INC | $124.86 | 2024 | Quviviq |
| Mylan Specialty L.P. | $123.39 | 2021 | |
| Argenx US, INC. | $85.99 | 2022 | |
| Novo Nordisk INC | $85.57 | 2022 | |
| Exact Sciences Corporation | $35.98 | 2023-2024 | Cologuard Collection Kit |
| Endotronix, INC. | $34.50 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Biohaven Pharmaceutical Holding Company LTD. | $19.29 | 2022 | |
| Insulet Corporation | $16.77 | 2024 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.